ArticleJACC. Case reports2026
Pulsed-Field Ablation of Atrial Tachycardia Originating From Bachmann's Bundle Via Epicardial Approach.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulsed-field ablation (PFA) may be effective for atrial tachycardia (AT) originating from Bachmann's bundle via epicardial mapping, but no such cases have been reported. CASE SUMMARY: A 40-year-old man with recurrent AT postatrial fibrillation ablation underwent repeat ablation with a focal PFA catheter. Activation mapping identified the earliest activation site at the Bachmann's bundle insertion in the left atrium, but PFA there was ineffective. Following pericardial puncture, the earliest activation point was mapped on the epicardial side at the corresponding endocardial Bachmann's bundle insertion site, 5.5 mm from the endocardial point. A single epicardial PFA application (1800V, 5 trains) immediately terminated the AT. However, AT recurred the next day, requiring radiofrequency ablation, after which it recurred again. DISCUSSION: This case demonstrates that PFA can successfully ablate refractory AT originating from epicardial Bachmann's bundle, but lesion depth may be limited by tissue thickness and epicardial fat, affecting long-term durability. TAKE-HOME MESSAGES: PFA could terminate epicardial Bachmann's bundle-mediated AT when endocardial ablation fails, but recurrence may occur due to limited lesion depth influenced by epicardial fat and tissue thickness. This suggests that the efficacy of PFA in thick-walled tissues remains somewhat constrained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.